What is Bristol-Myers Squibb's current debt?

Bristol-Myers Squibb (BMY) reported current debt of $1.03B in Q2 2026.

How has Bristol-Myers Squibb's current debt changed year-over-year?

Bristol-Myers Squibb's current debt decreased by 78.2% year-over-year, from $4.72B to $1.03B.

What is the long-term trend for Bristol-Myers Squibb's current debt?

Over 5 years (2020 to 2025), Bristol-Myers Squibb's current debt has grown at a 66.6% compound annual growth rate (CAGR), from $176M to $2.26B.

What does current debt mean?

The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.

Bristol-Myers Squibb BMY Current Debt

Current Debt at other companies

PfizerPFE

$3.86B+3.0%

Johnson & JohnsonJNJ

$11.69B+1.4%

IncyteINCY

$4.26M-4.8%

Gilead SciencesGILD

$1.31B-53.2%

CytokineticsCYTK

$44.81M+246%

ImmunityBio, Inc.IBRX

——

Other financials

Income statement

See full

Revenue$13.0B+5.7%

Gross profit$9.2B+3.9%

Net income$3.3B+153%

EPS (diluted)$1.62+153%

Balance sheet

See full

Cash & equivalents$8.7B-30.8%

Total debt$43.3B-12.3%

Total equity$22.3B+28.0%

Total assets$87.6B-7.4%

Cash flow

See full

Operating cash flow$3.4B-13.4%

CapEx$305.0M-15.5%

Free cash flow$3.1B-13.2%

Valuation

See full

Market cap$129.88B+36.2%

Enterprise value$164.48B+24.5%

P/E14×-5.2×

P/S2.6×+0.6×

Profitability

See full

Gross margin70.2%-0.1pp

Net margin18.9%+8.4pp

FCF margin23.3%-7.3pp

Returns & leverage

See full

Return on equity46.7%+17.8pp

Debt / equity1.9×-0.9×

Current ratio1.5×+0.3×

Where this comes from

Reported directly by Bristol-Myers Squibb in its filing.

Tagged under the XBRL concept us-gaap:ShortTermBorrowings.

The official record: Bristol-Myers Squibb’s 10-Q, filed July 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bristol-Myers Squibb's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bristol-Myers Squibb's current debt?: Bristol-Myers Squibb (BMY) reported current debt of $1.03B in Q2 2026.
How has Bristol-Myers Squibb's current debt changed year-over-year?: Bristol-Myers Squibb's current debt decreased by 78.2% year-over-year, from $4.72B to $1.03B.
What is the long-term trend for Bristol-Myers Squibb's current debt?: Over 5 years (2020 to 2025), Bristol-Myers Squibb's current debt has grown at a 66.6% compound annual growth rate (CAGR), from $176M to $2.26B.
What does current debt mean?: The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.